Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Anika Therapeutics (ANIK) Amortization - Goodwill (2020)

Anika Therapeutics (ANIK) has disclosed Amortization - Goodwill for 1 consecutive years, with $24.4 million as the latest value for Q4 2020.

  • Quarterly Amortization - Goodwill changed N/A to $24.4 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $24.4 million through Sep 2021, up 34.81% year-over-year, with the annual reading at $42.5 million for FY2020, N/A changed from the prior year.
  • Amortization - Goodwill for Q4 2020 was $24.4 million at Anika Therapeutics, up from $18.1 million in the prior quarter.
  • The five-year high for Amortization - Goodwill was $24.4 million in Q4 2020, with the low at $18.1 million in Q1 2020.